Advertisement
DOCS vs TTWO
Which Stock Would AI Choose? Doximity (DOCS) vs. Take-Two Interactive Software (TTWO) Stock Comparison
Key Takeaways
- DOCS is a profitable, high-margin digital network for physicians, while TTWO is a large video game publisher still generating GAAP net losses ahead of a major product catalyst.
- DOCS has faced decelerating growth and cautious forward guidance tied to pharmaceutical budget timing, pressuring its share price in recent periods.
- TTWO continues to deliver strong revenue and bookings growth, supported by recurring consumer spending and anticipation around upcoming franchise releases.
- Tickeron AI Verdict: Based on trend consistency, forward catalysts, and relative positioning, Tickeron's AI currently favors TTWO over DOCS.
- For additional context, explore DOCS Major News and DOCS Today's Price Move, as well as TTWO Major News and TTWO Today's Price Move.
- To see how automated strategies are navigating this market, explore Trending AI Robots.
Introduction
Investors evaluating growth-oriented technology names often weigh profitability against forward catalysts, and DOCS (Doximity, Inc.) and TTWO (Take-Two Interactive Software, Inc.) offer a clear contrast on that spectrum. Doximity operates a specialized professional network serving physicians and healthcare organizations, while Take-Two is a leading developer and publisher of interactive entertainment under brands including Rockstar Games, 2K, and Zynga. Although both companies are firmly anchored in digital ecosystems, their growth drivers, margin profiles, and risk factors differ substantially. This stock comparison is relevant for traders and investors seeking to understand how a profitable but decelerating healthcare platform stacks up against a larger, loss-generating entertainment company positioned around a significant upcoming product cycle.
DOCS Overview and Recent Performance
DOCS, or Doximity, operates a digital platform used by a large majority of U.S. physicians for collaboration, clinical workflow, telehealth, and career management. The company generates revenue primarily from pharmaceutical and health-system subscriptions, and it stands out for its profitability, with gross margins above 90% and a strong net cash position on its balance sheet.
In recent quarters, Doximity has reported continued revenue growth and rising engagement with its artificial intelligence tools, including its clinical reference and documentation products. However, recent market activity has been shaped by softer forward guidance. Management has cited delayed pharmaceutical industry budgets and policy-related pricing uncertainty as factors pushing some customer spending later in the year, while elevated investment in AI infrastructure has pressured operating margins. This combination of strong execution offset by cautious outlook has contributed to meaningful share-price volatility in recent weeks, with sentiment shifting as investors reassess the near-term growth trajectory.
TTWO Overview and Recent Performance
TTWO, or Take-Two Interactive Software, is a global developer, publisher, and distributor of interactive entertainment across console, PC, and mobile platforms. Its portfolio includes the Grand Theft Auto, NBA 2K, and Red Dead Redemption franchises, along with Zynga's mobile titles. The company has reported strong revenue and net bookings growth in recent periods, driven by recurring consumer spending and resilient demand for its established franchises.
Despite robust top-line momentum, Take-Two has continued to report GAAP net losses as it absorbs costs tied to acquisitions, amortization, and heavy investment in its development pipeline. Market sentiment in recent weeks has centered on the timing of upcoming releases, most notably the next installment of Grand Theft Auto, which is widely regarded as a key catalyst. The stock has shown sensitivity to product-related announcements, underscoring how much of the current valuation narrative rests on execution of its upcoming slate rather than near-term earnings.
Trending AI Robots
Tickeron's Trending AI Robots page is a curated showcase of automated trading strategies selected for their suitability to current market conditions. Tickeron hosts hundreds of AI trading bots that collectively monitor and trade thousands of different tickers, each operating with its own trading style, strategy, timeframe, and performance statistics. Because not every bot performs equally well in every environment, only the best-performing and most relevant strategies earn a place in this featured section. Traders can browse bots across varied approaches, from short-term momentum models to longer-horizon trend strategies, and review their historical statistics before making any decision. Explore Trending AI Robots to see which automated strategies are currently aligned with the market.
Head-to-Head Comparison
The most fundamental difference between these two companies is business model and profitability. DOCS is a subscription-driven software business with industry-leading margins and positive free cash flow, but its growth is tied to advertising and marketing budgets within the healthcare and pharmaceutical sectors, which can be cyclical and timing-sensitive. TTWO is a content-driven entertainment business whose revenue can be lumpy around release cycles, yet it benefits from highly durable recurring consumer spending and a loyal player base.
On growth drivers, Doximity's trajectory depends on adoption of its AI workflow tools and the pace at which delayed customer budgets convert into renewed spending. Take-Two's outlook is anchored to its franchise pipeline, where a single marquee release can meaningfully shift bookings and sentiment. In terms of risk, Doximity faces concentration in pharmaceutical clients and margin pressure from AI investment, while Take-Two carries execution risk around development timelines and a balance sheet still absorbing acquisition-related costs. From a market positioning standpoint, Doximity trades with a more modest market capitalization and a stronger profit record, whereas Take-Two commands a larger valuation supported by long-term earnings expectations rather than current GAAP profitability.
Tickeron AI Verdict
Based on observable factors, Tickeron's AI would currently lean toward TTWO in this comparison. While DOCS offers superior current profitability and a cleaner balance sheet, its recent guidance and revenue deceleration have introduced near-term uncertainty into its trend. Take-Two, by contrast, is exhibiting stronger relative momentum in revenue and bookings, narrowing losses, and a clearly defined forward catalyst in its upcoming release slate that tends to support trend consistency. This assessment is probabilistic rather than definitive, reflecting the relative positioning of each stock under current conditions rather than a prediction of future returns.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DOCS is a Hold and TTWO is a StrongBuy.
DOCS saw its Stochastic Oscillator leaves the overbought zone
The Stochastic Oscillator for DOCS moved out of overbought territory on November 02, 2026. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 56 similar instances where the indicator exited the overbought zone. In 47 of the 56 cases the stock moved lower. This puts the odds of a downward move at 84%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day RSI Indicator for DOCS moved out of overbought territory on October 29, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator moved out of overbought territory. In 20 of the 26 cases, the stock moved lower in the following days. This puts the odds of a move lower at 77%.
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on DOCS as a result. In 60 of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 77%.
The Moving Average Convergence Divergence Histogram (MACD) for DOCS turned negative on October 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 32 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 73%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DOCS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.
DOCS broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The 50-day moving average for DOCS moved above the 200-day moving average on October 14, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +3.54% 3-day Advance, the price is estimated to grow further. Considering data from situations where DOCS advanced for three days, in 210 of 281 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.
The Aroon Indicator entered an Uptrend today. In 125 of 180 cases where DOCS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 69%.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. DOCS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 51 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 68 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 82 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.326) is normal, around the industry mean (4.477). P/E Ratio (36.122) is within average values for comparable stocks, (13.414). Projected Growth (PEG Ratio) (0.590) is also within normal values, averaging (2.133). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (7.776) is also within normal values, averaging (6.065).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DOCS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.
TTWO's RSI Oscillator climbs out of oversold territory
The RSI Indicator for TTWO moved out of oversold territory on November 02, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 31 similar instances when the indicator left oversold territory. In 26 of the 31 cases the stock moved higher. This puts the odds of a move higher at 84%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on TTWO as a result. In 55 of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 68%.
The Moving Average Convergence Divergence (MACD) for TTWO just turned positive on November 04, 2026. Looking at past instances where TTWO's MACD turned positive, the stock continued to rise in 36 of 47 cases over the following month. The odds of a continued upward trend are 77%.
TTWO moved above its 50-day moving average on November 04, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +2.86% 3-day Advance, the price is estimated to grow further. Considering data from situations where TTWO advanced for three days, in 220 of 327 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.
TTWO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The 50-day moving average for TTWO moved below the 200-day moving average on October 07, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TTWO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 57%.
The Aroon Indicator for TTWO entered a downward trend on October 20, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 32 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 57 (best 1 - 100 worst), indicating steady price growth. TTWO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 74 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TTWO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.
The Tickeron Valuation Rating of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (11.134) is normal, around the industry mean (12.346). TTWO's P/E Ratio (-124.202) is considerably lower than the industry average of (-4.296). Projected Growth (PEG Ratio) (2.772) is also within normal values, averaging (2.125). Dividend Yield (0.000) settles around the average of (2.202) among similar stocks. TTWO's P/S Ratio (5.869) is very high in comparison to the industry average of (1.575).
The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
TTWO | ||
|---|---|---|
OUTLOOK RATING 1..100 | 16 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 85 Overvalued | |
PROFIT vs RISK RATING 1..100 | 74 | |
SMR RATING 1..100 | 93 | |
PRICE GROWTH RATING 1..100 | 57 | |
P/E GROWTH RATING 1..100 | 32 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| DOCS | TTWO | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 77% | 1 day ago 84% |
| Stochastic ODDS (%) | 1 day ago 84% | 1 day ago 63% |
| Momentum ODDS (%) | 1 day ago 77% | 1 day ago 68% |
| MACD ODDS (%) | 1 day ago 73% | 1 day ago 77% |
| TrendWeek ODDS (%) | 1 day ago 74% | 1 day ago 65% |
| TrendMonth ODDS (%) | 1 day ago 78% | 1 day ago 55% |
| Advances ODDS (%) | 13 days ago 75% | 4 days ago 67% |
| Declines ODDS (%) | 4 days ago 78% | 11 days ago 57% |
| BollingerBands ODDS (%) | 1 day ago 79% | 1 day ago 73% |
| Aroon ODDS (%) | 1 day ago 69% | 1 day ago 64% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
DOCS’s FA Score shows that 0 FA rating(s) are green while TTWO’s FA Score has 1 green FA rating(s).
- DOCS’s FA Score: 0 green, 5 red.
- TTWO’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
DOCS’s TA Score shows that 3 TA indicator(s) are bullish while TTWO’s TA Score has 6 bullish TA indicator(s).
- DOCS’s TA Score: 3 bullish, 6 bearish.
- TTWO’s TA Score: 6 bullish, 4 bearish.
Price Growth
DOCS (@Services to the Health Industry) experienced а 0.00% price change this week, while TTWO (@Electronics/Appliances) price change was +7.96% for the same time period.
The average weekly price growth across all stocks in the @Services to the Health Industry industry was +3.24%. For the same industry, the average monthly price growth was +2.73%, and the average quarterly price growth was +21.69%.
The average weekly price growth across all stocks in the @Electronics/Appliances industry was +0.57%. For the same industry, the average monthly price growth was -8.70%, and the average quarterly price growth was -15.31%.
Reported Earning Dates
DOCS is expected to report earnings on Feb 11, 2027.
TTWO is expected to report earnings on Feb 08, 2027.
Industries' Descriptions
@Services to the Health Industry (+3.24% weekly)This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.
@Electronics/Appliances (+0.57% weekly)TVs, telephones, washing machines, home speakers and even home-office equipment like computers and printers…the list is virtually endless when it comes to consumer electronics and appliances. And, with ‘smarthomes’ increasingly becoming the reality, we could see a sharp surge in high-tech gadgets (including robotic appliances) making their way into our homes– and therefore spelling plenty opportunities in the related industries. Consumers account for 70% of US GDP, and their purchases of high-functioning electronics could make significant dents in the economy’s health. Sony Corp., Whirlpool and iRobot are some of the major consumer electronics/appliances makers.
Advertisement
DOCS and
Correlation & Price change
A.I.dvisor indicates that over the last year, DOCS has been loosely correlated with COIN. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if DOCS jumps, then COIN could also see price increases.
| Ticker / NAME | Correlation To DOCS | 1D Price Change % | ||
|---|---|---|---|---|
| DOCS | 100% | +1.11% | ||
| COIN - DOCS | 57% Loosely correlated | +0.99% | ||
| PUBM - DOCS | 54% Loosely correlated | +6.85% | ||
| CLSK - DOCS | 53% Loosely correlated | +12.18% | ||
| COMP - DOCS | 53% Loosely correlated | +5.68% | ||
| RIOT - DOCS | 49% Loosely correlated | +5.69% | ||
More | ||||